Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11377450 Functionalized heterocycles as antiviral agents

Patent 11377450 was granted and assigned to Enanta Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113774500

Patent Inventor Names

Dexter Davis0

Joseph Panarese0

Katherine Chong0

Samuel Bartlett0

Yat Sun Or0

Date of Patent

July 5, 2022

Patent Application Number

170839750

Date Filed

October 29, 2020

Patent Citations

‌

US Patent 10179131 Hepatitis B antiviral agents

‌

US Patent 10179792 Hepatitis B antiviral agents

‌

US Patent 10189846 Hepatitis B antiviral agents

‌

US Patent 10428070 Hepatitis B antiviral agents

‌

US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound

‌

US Patent 10538532 Hepatitis B antiviral agents

‌

US Patent 10640511 Hepatitis B antiviral agents

‌

US Patent 10723733 Hepatitis B antiviral agents

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11377450 Functionalized heterocycles as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API